Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical modelsStefano Pierini, Michael Klichinsky|Nature Communications|2025Cited by 80
Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapyMireia Uribe‐Herranz, Andrea Facciabene, Marco Ruella et al.|Molecular Therapy|2023Cited by 57
Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic targetStefano Pierini, Andrea Facciabene|JCI Insight|2020Cited by 27